Global & Public Health (all articles)
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.
15 Dec, 2021 | 08:43h | UTCNews release: COVID-19 infection, more likely than vaccines, to cause rare cardiovascular complications – University of Oxford
Commentaries on Twitter
Hugely important work from @JuliaHCox and colleagues:
In people <40, Pfizer carries a much lower risk of myocarditis than either Moderna **or SARS-CoV-2 infection** (annotations added)https://t.co/wqRts3ALqy pic.twitter.com/fnn1T39h1b
— David Juurlink (@DavidJuurlink) December 14, 2021
A case series published in @NatureMedicine shows an increased risk of myocarditis after receiving the Astra-Zeneca-Oxford, Pfizer-BioNTech and the Moderna COVID-19 vaccines, but SARS-CoV-2 infection carried a greater risk of myocarditis. https://t.co/6y7pZlJN70 pic.twitter.com/cBlKz9sUkg
— Nature Portfolio (@NaturePortfolio) December 14, 2021
Just published @NatureMedicine
The most comprehensive assessment of the rare events of myocarditis, pericarditis, arrhythmias after COVID and AZ, mRNA vaccineshttps://t.co/0bEdMJSLXg pic.twitter.com/eC5JOx0CmG— Eric Topol (@EricTopol) December 14, 2021
[Press release – not published yet] Pfizer’s Covid pill remains 89% effective for reducing the risk of hospitalization or death in final analysis.
15 Dec, 2021 | 08:46h | UTCCommentaries:
Pfizer’s Covid pill remains 89% effective in final analysis, company says – STAT
Pfizer confirms COVID pill’s results, potency versus omicron – Associated Press
Related:
8 lingering questions about the new Covid pills from Merck and Pfizer.
Commentary on Twitter (thread – click for more)
@pfizer releases more nirmatrelvir (#Paxlovid) data on #COVID19 final outcomes. Data are consistent, slightly better thant interim analysis. #IDTwitter
▪️ 88% overall hospitalization <=5days
▪️ No deaths in High Risk Trial (EPIC-HR)
▪️ Stopping drug 2.1%https://t.co/1D2LKan7tM— David Boulware, MD MPH (@boulware_dr) December 14, 2021
Rapidly spreading Omicron is now in 77 countries and WHO warns against assuming its effects are mild.
15 Dec, 2021 | 08:39h | UTC
Study suggests COVID-19 certificates may boost vaccine uptake in countries with below average coverage.
15 Dec, 2021 | 08:41h | UTCNews Release: COVID-19 certificates may boost vaccine uptake in countries with below average coverage – University of Oxford
Original Study: The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries – The Lancet Public Health
Commentary on Twitter
https://twitter.com/ruettenauer/status/1470675353937063937
COVID-19 in 2022: controlling the pandemic is within our grasp.
15 Dec, 2021 | 08:36h | UTCCOVID-19 in 2022: controlling the pandemic is within our grasp – Nature Medicine
Commentaries on Twitter
What will the COVID-19 pandemic look like in 2022?
Who better to ask than @mvankerkhove, one of the busiest people in the world right now, who took the time to write this thoughtful World View for @NatureMedicine.https://t.co/jgodgPIDrK
— Ben Johnson 🦠📝 (@drbenjohnson) December 14, 2021
Vaccine inequity, inconsistent public health measures and new variants such as Omicron are prolonging the COVID-19 pandemic, but controlling the virus remains possible.
Worldview from @mvankerkhove @WHOhttps://t.co/vLmASqI8i7
— Nature Medicine (@NatureMedicine) December 14, 2021
[Not published yet] Initial data from South Africa showed vaccine protection vs. Omicron infection may drop to 30% but does cut severe disease.
15 Dec, 2021 | 08:38h | UTCVaccine protection vs. omicron infection may drop to 30% but does cut severe disease – NPR
See also: South Africa Omicron study finds drop in vaccine protection, fewer hospitalized – CIDRAP
Omicron: WHO updated technical brief and priority actions.
14 Dec, 2021 | 09:50h | UTC
Commentary on Twitter (thread – click for more)
🆕 Technical Brief & Priority Actions for Member States on enhancing readiness for Omicron https://t.co/tOu6iIvFZP #COVID19 pic.twitter.com/huPP4QFS35
— World Health Organization (WHO) (@WHO) December 12, 2021
[Preprint] SARS-CoV-2 variant Omicron evades neutralization by sera from vaccinated and convalescent individuals.
14 Dec, 2021 | 09:46h | UTCCommentary: SARS-CoV-2 omicron variant may evade host immune responses – News Medical
Commentary on Twitter (thread – click for more)
⚠️OMICRON “EVADES” NEUTRALIZATION—1st ever #Omicron variant study of blood from Moderna, Oxford-AstraZeneca, Pfizer vaccinated, vs survivors of Alpha, Beta, Delta variants. Omicron #B11529 evasive—but 2x Pfizer/mixed stronger>> convalescent; 3x hit best.🧵 https://t.co/292o740rHy pic.twitter.com/NYei6MACkj
— Eric Feigl-Ding (@DrEricDing) December 13, 2021
Recommendations for equitable COVID-19 pandemic recovery in Canada.
14 Dec, 2021 | 09:47h | UTCNews Release: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal
Editorial: Build back more equitably
WHO Reports | More than half a billion people pushed or pushed further into extreme poverty due to health care costs.
14 Dec, 2021 | 08:55h | UTCReport 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Report 2: Global monitoring report on financial protection in health 2021 – World Health Organization
WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.
14 Dec, 2021 | 08:53h | UTC
Commentary on Twitter
🆕 WHO report shows that investing only 1⃣ USD per person per year in the prevention and control of noncommunicable diseases could save almost 7⃣ million lives 🌍 by 2030. Let's #BeatNCDs!https://t.co/KP71n5M1cY pic.twitter.com/kviaoWc2J5
— World Health Organization (WHO) (@WHO) December 13, 2021
[Preprint] COVID vaccines cut the risk of transmitting Delta — but not for long
14 Dec, 2021 | 09:42h | UTCCOVID vaccines cut the risk of transmitting Delta — but not for long – Nature
Original Study [preprint]: The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission – medRxiv
An observational study showed Moderna is associated with increased effectiveness vs. Pfizer vaccine against symptomatic SARS-CoV-2 infection.
13 Dec, 2021 | 09:52h | UTCComparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection – Med
Related:
Opinion | Is Moderna really better than Pfizer—or is it just a higher dose?
Commentary on Twitter
New @MedCellPress
Comparative effectiveness of the Pfizer and Moderna vaccines over time, in both the Alpha and Delta US waves, vs symptomatic infections https://t.co/RlWUXeZ2f2
consistent 8-12 % points advantage for Moderna pic.twitter.com/IwHXFIKaEp— Eric Topol (@EricTopol) December 11, 2021
Perspective: Alcohol-related harm is a public health issue, not a lifestyle choice.
14 Dec, 2021 | 08:41h | UTCAlcohol-related harm is a public health issue, not a lifestyle choice – Health Policy Watch
Related:
COVID-19 pandemic and alcohol consumption: Impacts and interconnections – Toxicology Reports
National, Regional, and Global Burdens of Disease Attributable to Alcohol Use
Study: Alcohol Use and Burden for 195 Countries and Territories
Study: The Global Burden of Disease Attributable to Alcohol and Drug Use
Study: Global Alcohol Exposure Between 1990 and 2017 and Forecasts Until 2030
Analysis: Prioritizing Action on Alcohol for Health and Development
Research: Contribution of alcohol use disorders to the burden of dementia
UK Report on SARS-CoV-2 variants of concern finds significantly lower vaccine effectiveness (VE) against Omicron infection, but a moderate to high VE of 70 to 75% is seen after a third (booster) dose.
13 Dec, 2021 | 09:53h | UTCCommentaries:
Omicron: Three vaccine doses key for protection against variant – BBC
Two jabs offer little protection against Omicron infection, UK data shows – The Guardian
UK Says Omicron to Become Its Dominant Variant Within Days – Associated Press
Covid-19: Do vaccines work against omicron—and other questions answered.
13 Dec, 2021 | 09:49h | UTCCovid-19: Do vaccines work against omicron—and other questions answered – The BMJ
Fauci says Omicron-specific version of Covid-19 vaccines may not be necessary.
13 Dec, 2021 | 09:51h | UTCFauci says Omicron-specific version of Covid-19 vaccines may not be necessary – STAT
Opinion: Revoke the Omicron travel ban against African countries.
13 Dec, 2021 | 09:48h | UTCRevoke the Omicron Travel Ban Against African Countries – The New York Times (a few articles per month are free)
Commentary on Twitter
Revoke the Omicron Travel Ban Against African Countries https://t.co/RhuHtnCYgR. Well said @SaadOmer3 this is not based in science and simply unjustifiable and needs to end now.
— Carlos del Rio (@CarlosdelRio7) December 11, 2021
Colorectal cancer incidence, mortality, tumor characteristics, and treatment before and after the introduction of the fecal immunochemical testing-based screening program in the Netherlands: a population-based study.
13 Dec, 2021 | 08:50h | UTCColorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Breekveldt et al – #Colorectalcancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the FIT-based #screening programme in the #Netherlands: a population-based studyhttps://t.co/nW9SVAhRxE#GITwitter #crcsm pic.twitter.com/GGRF9Az0tg
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 23, 2021
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.
10 Dec, 2021 | 10:23h | UTC
Commentary on Twitter
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact https://t.co/dd91AkYmu4 pic.twitter.com/1ByzLeTdlh
— Nature Rev Immunol (@NatRevImmunol) December 7, 2021
Editorial | Emerging SARS-CoV-2 variants: shooting the messenger.
10 Dec, 2021 | 10:19h | UTCEmerging SARS-CoV-2 variants: shooting the messenger – The Lancet Infectious Diseases
Commentary on Twitter
"Omicron is the latest variant but is unlikely to be the last. We cannot risk disincentivising nations from alerting the world to new variants. In fact, globally, we would benefit from upscaling genomic surveillance" @TheLancetInfDis #IDTwitter #MedEd https://t.co/3Mz6WAgsKD
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) December 9, 2021
The emergence, genomic diversity and global spread of SARS-CoV-2.
10 Dec, 2021 | 10:21h | UTCThe emergence, genomic diversity and global spread of SARS-CoV-2 – Nature
Omicron spreads, but severe cases remain low in South Africa.
10 Dec, 2021 | 10:17h | UTCOmicron spreads but severe cases remain low in South Africa – WHO Africa
Infodemics: a new challenge for public health.
10 Dec, 2021 | 10:18h | UTCInfodemics: A new challenge for public health – Cell
See also:
What is an infodemic and how can we prevent it?
Commentary on Twitter
What pandemics and infodemics don’t have in common could help us learn how to fight them, experts suggest in a new @CellCellPress Commentary. Read more here: https://t.co/15nVCiebLI@Walter4C pic.twitter.com/7viNB9yRvR
— Cell Press (@CellPressNews) December 9, 2021
CDC chief says Omicron is ‘mild’ as early data comes in on US spread of variant.
10 Dec, 2021 | 10:14h | UTCCDC chief says Omicron is ‘mild’ as early data comes in on US spread of variant – The Guardian


